RxDoctor Payments Data

Scott Dalton, DO

Dermatopathology · Lackland Afb, TXNPI 1497725576

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.9% of the total across 306 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations.

$6,318in general payments, 2019–2025

Across 306 payments — averaging $20.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Galderma Laboratories, L.p.$945
  • AbbVie$625
  • E.r. Squibb & Sons, L.L.C.$469
  • Lilly USA, LLC$408
  • Sanofi$388
  • Sun Pharmaceutical Industries Inc.$349
  • plus $3K from 25 others

What the payments were for

  • Food & beverage$6,310100%
  • Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,318 in reported general payments places this provider in the 65th percentile of 54 dermatopathology providers in Texas.

See all dermatopathology providers in Texas

Medicare billing

Part B allowed, 2024
$631,657
Medicare patients
2,199
Services billed
9,273

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab14$52,037
Tacrolimus44$6,215
Clobetasol Propionate29$1,952
Ivermectin11$1,937
Fluocinonide46$1,643
Fluorouracil20$1,434
Triamcinolone Acetonide99$1,315
Pimecrolimus11$1,309
Fluocinolone Acetonide18$935
Ketoconazole90$927
Metronidazole12$787
Desonide14$506
Doxycycline Hyclate15$263
Hydrocortisone55$243
Clindamycin Phosphate13$222

Paid to pharmacies, not to this prescriber.

Other dermatopathology in Lackland Afb

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →